<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Release of the excitatory neurotransmitter <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> and the excessive stimulation of <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>)-type <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptors is thought to be responsible for much of the neuronal <z:hpo ids='HP_0011420'>death</z:hpo> that occurs following focal <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the central <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="1" pm="."><plain>Our laboratory has identified endogenous sulfated steroids that potentiate or inhibit <z:chebi fb="0" ids="31882">NMDA</z:chebi>-induced currents </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report that 3alpha-ol-5beta-pregnan-20-one hemisuccinate (3alpha5betaHS), a synthetic homologue of naturally occurring <z:chebi fb="0" ids="1712">pregnanolone</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi>, inhibits <z:chebi fb="0" ids="31882">NMDA</z:chebi>-induced currents and cell <z:hpo ids='HP_0011420'>death</z:hpo> in primary cultures of rat hippocampal neurons </plain></SENT>
<SENT sid="3" pm="."><plain>3alpha5betaHS exhibits sedative, <z:chebi fb="0" ids="35623">anticonvulsant</z:chebi>, and <z:chebi fb="29" ids="35480">analgesic</z:chebi> properties consistent with an action at <z:chebi fb="0" ids="31882">NMDA</z:chebi>-type <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptors </plain></SENT>
<SENT sid="4" pm="."><plain>Intravenous administration of 3alpha5betaHS to rats (at a nonsedating dose) following focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> significantly reduces cortical and subcortical <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="5" pm="."><plain>The in vitro and in vivo neuroprotective effects of 3alpha5betaHS demonstrate that this steroid represents a new class of potentially useful therapeutic agents for the treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> and certain <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> that involve over activation of <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors </plain></SENT>
</text></document>